Skip to content

Ardelyx ARDX Debt-to-assets

Debt-to-assets at other companies

Amgen logo
AmgenAMGN
0.6×0.0×
Bausch Health Companies logo
Bausch Health CompaniesBHC
0.8×0.0×
AbbVie logo
AbbVieABBV
0.5×0.0×
XER
Xeris Biopharma Holdings, Inc.XERS
0.7×-0.2×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
0.3×0.0×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.1×0.0×

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on the most recent quarter.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's debt-to-assets?
Ardelyx (ARDX) reported debt-to-assets of 0.4× in Q1 2026.
How has Ardelyx's debt-to-assets changed year-over-year?
Ardelyx's debt-to-assets increased by 9.2% year-over-year, from 0.4× to 0.4×.
What is the long-term trend for Ardelyx's debt-to-assets?
Over 5 years (2020 to 2025), Ardelyx's debt-to-assets has grown at a 101.1% compound annual growth rate (CAGR), from 0× to 0.4×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.